Deepak Gulati‘s Switzerland-based fund, Argentiere Capital recently disclosed its equity holdings as of the end of the first quarter in a filing...
Keep Reading →
April 28 - Hedge Funds, News - Comments
Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners has filed its latest 13F, and there has been a good deal of turnover in the fund’s equity...
Keep Reading →
April 24 - Hedge Funds, News - Comments
Raptor Capital Management is a hedge fund founded by James Pallotta. As a part of Raptor Group Holdings, this hedge fund specializes in investing in public...
Keep Reading →
April 17 - Hedge Funds, News - Comments
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last...
Keep Reading →
February 9 - Hedge Funds, News - Comments
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1....
Keep Reading →
September 15 - News - Comments
Hospira, Inc. (NYSE:HSP) announced that the European Commission has approved its biosimilar version of Remicade from Johnson & Johnson (NYSE:JNJ...
Keep Reading →
September 12 - News - Comments
What’s a smart Alkermes Plc (NASDAQ:ALKS) investor to do? In the financial world, there are plenty of indicators shareholders can use to watch...
Keep Reading →
September 3 - News - Comments
Now, according to many of your fellow readers, hedge funds are seen as useless, old investment tools of a period lost to current times. Although there...
Keep Reading →
August 27 - News - Comments
To the average investor, there are a multitude of gauges shareholders can use to analyze their holdings. Two of the most useful are hedge fund and insider...
Keep Reading →
August 26 - News - Comments
What do hedge funds think about Valeant Pharmaceuticals Intl Inc (NYSE:VRX)? At the moment, there are tons of gauges investors can use to track Mr. Market...
Keep Reading →
August 23 - News - Comments
Maybe Texas just needs to fire up Ol’ Sparky again. With the pace of executions in the state, it’s fast running out of pentobarbital, the...
Keep Reading →
August 5 - News - Comments
It isn’t very often that an agency sometimes accused of over-regulating an industry can be ridiculed for not regulating enough, but that’s...
Keep Reading →
August 2 - News - Comments
ICU Medical, Incorporated (NASDAQ:ICUI)’s share price jumped sharply in early May after media outlets reported potential buyer interest in the medical...
Keep Reading →
July 29 - News - Comments
Arthritis biologics like Remicade, Enbrel, and Humira are pricy drugs that many of the 50 million American arthritis patients – and hundreds of millions...
Keep Reading →
July 16 - News - Comments
What’s the worst nightmare of all pharmaceutical companies? Generics. They might as well be the grim reaper in the eyes of the brand-name pharmaceuticals...
Keep Reading →
July 2 - News - Comments
According to IMS health report, the global pharmaceutical industry is expected to grow at a CAGR of 4.5% in the next five years to reach $1.20 trillion...
Keep Reading →
July 2 - News - Comments
At the London Value Investor Conference, famous value investor Michael Price pitched Hospira, Inc. (NYSE:HSP) as one of his favorite stocks. As of March...
Keep Reading →
July 1 - News - Comments
At the London Value Investor Conference, famous value investor Michael Price pitched Hospira, Inc. (NYSE:HSP) as one of his favorite stocks. As of March...
Keep Reading →
June 24 - News - Comments
Nothing interests a value investor more than bad news. Where there’s a lack of enthusiasm, there’s usually a cheap stock. Hospira, Inc. (...
Keep Reading →
June 14 - News - Comments
Hospira, Inc. (NYSE:HSP) shareholders have witnessed a decrease in activity from the world’s largest hedge funds in recent months. At the moment...
Keep Reading →
May 29 - News - Comments
Whether you are an aggressive, shoot-for-the-moon investor or a conservative coupon clipper, you are constantly faced with an oft-debated investor’s...
Keep Reading →
April 1 - News - Comments
The Ides of March meant bad news for Julius Caesar. Similarly, the week surrounding the Ides of February haven’t turned out so well for several...
Keep Reading →
February 16 - News - Comments
No matter the market, there will always be losers — a few lagging disappointments holding back a Wall Street rally, or several big losers leading...
Keep Reading →
February 14 - News - Comments
13F filings are made within several weeks after the end of a quarter and disclose many of the long equity positions held by a hedge fund or other major...
Keep Reading →
February 11 - Hedge Funds - Comments
Unless you are a trader that measures holding periods in days, the short answer is nothing. The S&P 500 has raced out of the gate to start 2013...
Keep Reading →
February 1 - News - Comments
Between April and June of this year, Orbimed Advisors sold 18% of its shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), finishing the second quarter...
Keep Reading →
October 1 - Hedge Funds - Comments
Ole Andreas Halvorsen is one of the most successful Tiger cubs. Norwegian Halvorsen launched Viking Global at the end of 1999 with former Tiger employees...
Keep Reading →
February 13 - News - Comments
